• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

FDG 联合 PiB PET 在记忆门诊认知障碍患者诊断中的价值。

The value of FDG combined with PiB PET in the diagnosis of patients with cognitive impairment in a memory clinic.

机构信息

Department of Neurology, Tianjin Neurological Institute, Tianjin Medical University General Hospital, Tianjin, China.

Health Management Center, Tianjin Medical University General Hospital Airport Site, Tianjin, China.

出版信息

CNS Neurosci Ther. 2024 Feb;30(2):e14418. doi: 10.1111/cns.14418. Epub 2023 Aug 21.

DOI:10.1111/cns.14418
PMID:37602885
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10848040/
Abstract

AIMS

To analyze the value of F-fluorodeoxyglucose (FDG) positron emission tomography (PET) combined with amyloid PET in cognitive impairment diagnosis.

METHODS

A total of 187 patients with dementia or mild cognitive impairment (MCI) who underwent C-Pittsburgh compound B (PiB) and FDG PET scans in a memory clinic were included in the final analysis.

RESULTS

Amyloid-positive and amyloid-negative dementia patient groups showed a significant difference in the proportion of individuals presenting temporoparietal cortex (p < 0.001) and posterior cingulate/precuneus cortex (p < 0.001) hypometabolism. The sensitivity and specificity of this hypometabolic pattern for identifying amyloid pathology were 72.61% and 77.97%, respectively, in patients clinically diagnosed with AD and 60.87% and 76.19%, respectively, in patients with MCI. The initial diagnosis was changed in 32.17% of patients with dementia after considering both PiB and FDG results. There was a significant difference in both the proportion of patients showing the hypometabolic pattern and PiB positivity between dementia conversion patients and patients with a stable diagnosis of MCI (p < 0.05).

CONCLUSION

Temporoparietal and posterior cingulate/precuneus cortex hypometabolism on FDG PET suggested amyloid pathology in patients with cognitive impairment and is helpful in diagnostic decision-making and predicting AD dementia conversion from MCI, particularly when combined with amyloid PET.

摘要

目的

分析 F-氟脱氧葡萄糖(FDG)正电子发射断层扫描(PET)联合淀粉样 PET 在认知障碍诊断中的价值。

方法

最终分析了在记忆诊所接受 C-匹兹堡化合物 B(PiB)和 FDG PET 扫描的 187 名痴呆或轻度认知障碍(MCI)患者。

结果

淀粉样阳性和淀粉样阴性痴呆患者组在颞顶叶皮层(p < 0.001)和后扣带回/楔前叶皮层(p < 0.001)代谢低下的个体比例上存在显著差异。这种代谢低下模式识别淀粉样蛋白病理学的敏感性和特异性分别为临床诊断为 AD 的患者 72.61%和 77.97%,MCI 的患者分别为 60.87%和 76.19%。考虑到 PiB 和 FDG 结果后,痴呆患者中有 32.17%的初始诊断发生了改变。在认知障碍转换患者和 MCI 稳定诊断患者之间,显示代谢低下模式和 PiB 阳性的患者比例存在显著差异(p < 0.05)。

结论

FDG PET 显示的颞顶叶和后扣带回/楔前叶皮层代谢低下提示淀粉样蛋白病理学存在于认知障碍患者中,有助于诊断决策和预测从 MCI 向 AD 痴呆的转化,尤其是与淀粉样 PET 结合时。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7fde/10848040/95162ec61ddd/CNS-30-e14418-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7fde/10848040/9f57fc86fe50/CNS-30-e14418-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7fde/10848040/1e8ca2f79ebf/CNS-30-e14418-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7fde/10848040/95162ec61ddd/CNS-30-e14418-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7fde/10848040/9f57fc86fe50/CNS-30-e14418-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7fde/10848040/1e8ca2f79ebf/CNS-30-e14418-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7fde/10848040/95162ec61ddd/CNS-30-e14418-g003.jpg

相似文献

1
The value of FDG combined with PiB PET in the diagnosis of patients with cognitive impairment in a memory clinic.FDG 联合 PiB PET 在记忆门诊认知障碍患者诊断中的价值。
CNS Neurosci Ther. 2024 Feb;30(2):e14418. doi: 10.1111/cns.14418. Epub 2023 Aug 21.
2
Visual Versus Fully Automated Analyses of 18F-FDG and Amyloid PET for Prediction of Dementia Due to Alzheimer Disease in Mild Cognitive Impairment.18F-FDG和淀粉样蛋白PET的视觉分析与全自动分析对轻度认知障碍患者阿尔茨海默病所致痴呆的预测作用
J Nucl Med. 2016 Feb;57(2):204-7. doi: 10.2967/jnumed.115.163717. Epub 2015 Nov 19.
3
Diagnostic role of 11C-Pittsburgh compound B retention patterns and glucose metabolism by fluorine-18-fluorodeoxyglucose PET/CT in amnestic and nonamnestic mild cognitive impairment patients.11C-匹兹堡化合物B滞留模式及18F-氟脱氧葡萄糖PET/CT检测的葡萄糖代谢在遗忘型和非遗忘型轻度认知障碍患者中的诊断作用
Nucl Med Commun. 2016 Nov;37(11):1189-96. doi: 10.1097/MNM.0000000000000569.
4
Amyloid load but not regional glucose metabolism predicts conversion to Alzheimer's dementia in a memory clinic population.淀粉样蛋白负荷而非区域性葡萄糖代谢可预测记忆门诊人群向阿尔茨海默病痴呆的转化。
Eur J Nucl Med Mol Imaging. 2018 Jul;45(8):1442-1448. doi: 10.1007/s00259-018-3983-6. Epub 2018 Mar 15.
5
A Cross-Validation of FDG- and Amyloid-PET Biomarkers in Mild Cognitive Impairment for the Risk Prediction to Dementia due to Alzheimer's Disease in a Clinical Setting.在临床环境中,对轻度认知障碍患者进行氟代脱氧葡萄糖(FDG)和淀粉样蛋白正电子发射断层扫描(PET)生物标志物的交叉验证,以预测阿尔茨海默病所致痴呆的风险
J Alzheimers Dis. 2017;59(2):603-614. doi: 10.3233/JAD-170158.
6
The use of individual-based FDG-PET volume of interest in predicting conversion from mild cognitive impairment to dementia.使用基于个体的 FDG-PET 感兴趣区容积预测从轻度认知障碍到痴呆的转化。
BMC Med Imaging. 2024 Mar 28;24(1):75. doi: 10.1186/s12880-024-01256-x.
7
Clinical, Neuropsychological, and Neuroimaging Characteristics of Amyloid- positive vs. Amyloid-negative Patients with Clinically Diagnosed Alzheimer's Disease and Amnestic Mild Cognitive Impairment.与临床诊断的阿尔茨海默病和遗忘型轻度认知障碍的淀粉样蛋白阴性患者相比,淀粉样蛋白阳性患者的临床、神经心理学和神经影像学特征。
Curr Alzheimer Res. 2021;18(6):523-532. doi: 10.2174/1567205018666211001113349.
8
Parallel ICA of FDG-PET and PiB-PET in three conditions with underlying Alzheimer's pathology.在三种存在潜在阿尔茨海默病病理学特征的情况下,对氟代脱氧葡萄糖正电子发射断层扫描(FDG-PET)和匹兹堡化合物B正电子发射断层扫描(PiB-PET)进行并行独立成分分析。
Neuroimage Clin. 2014 Mar 19;4:508-16. doi: 10.1016/j.nicl.2014.03.005. eCollection 2014.
9
Amyloid imaging with (11)C-PIB PET/CT and glucose metabolism with (18)F-FDG PET/CT in a study on cognitive impairment in the clinical setting.在一项关于临床环境中认知障碍的研究中,使用(11)C-PIB PET/CT进行淀粉样蛋白成像以及使用(18)F-FDG PET/CT进行葡萄糖代谢成像。
Nucl Med Commun. 2014 Mar;35(3):238-44. doi: 10.1097/MNM.0000000000000042.
10
Quantitative longitudinal interrelationships between brain metabolism and amyloid deposition during a 2-year follow-up in patients with early Alzheimer's disease.在早期阿尔茨海默病患者 2 年随访期间,大脑代谢与淀粉样蛋白沉积的定量纵向相互关系。
Eur J Nucl Med Mol Imaging. 2012 Dec;39(12):1927-36. doi: 10.1007/s00259-012-2230-9. Epub 2012 Aug 28.

引用本文的文献

1
Cerebral perfusion is correlated with cerebral metabolism and amyloid deposition in Alzheimer's disease.在阿尔茨海默病中,脑灌注与脑代谢及淀粉样蛋白沉积相关。
Transl Psychiatry. 2025 Jun 4;15(1):189. doi: 10.1038/s41398-025-03402-7.
2
Plasma biomarkers for diagnosis and differentiation and their cognitive correlations in patients with Alzheimer's disease.阿尔茨海默病患者诊断与鉴别诊断的血浆生物标志物及其认知相关性
Brain Commun. 2025 Feb 25;7(2):fcaf094. doi: 10.1093/braincomms/fcaf094. eCollection 2025.
3
Cerebral perfusion correlates with amyloid deposition in patients with mild cognitive impairment due to Alzheimer's disease.
在因阿尔茨海默病导致轻度认知障碍的患者中,脑灌注与淀粉样蛋白沉积相关。
J Prev Alzheimers Dis. 2025 Feb;12(2):100031. doi: 10.1016/j.tjpad.2024.100031. Epub 2025 Jan 1.
4
Two decades of [C]PiB synthesis, 2003-2023: a review.2003年至2023年[C]PiB合成的二十年回顾
Am J Nucl Med Mol Imaging. 2024 Feb 20;14(1):48-62. doi: 10.62347/ADSK6584. eCollection 2024.
5
Incremental value of amyloid PET in a tertiary memory clinic setting in China.在中国的三级记忆诊所环境中淀粉样蛋白 PET 的增值作用。
Alzheimers Dement. 2024 Apr;20(4):2516-2525. doi: 10.1002/alz.13728. Epub 2024 Feb 8.